Answers are grounded in this paper and cite their sources.
Background Huatanqushihuoxue formula (HQHF) exerts antioxidant and anti-inflammatory effects and alleviates hepatic inflammatory injury and fibrosis. Neutrophil extracellular traps (NETs) in the inflammatory microenvironment of metabolic dysfunction-associated steatohepatitis (MASH) regulate mitochondrial respiration in CD4 + T cells, promote regulatory T cell (Treg) differentiation, and mediate inflammation–cancer transformation. However, whether HQHF improves the immune microenvironment during MASH–hepatocellular carcinoma (HCC) progression by regulating the NETs/CD4 + T/Tregs axis remains unclear. This study aimed to investigate the correlation. Methods MASH-HCC rat models were established using a choline-deficient L-amino acid-defined (CDAA) diet combined with diethylnitrosamine (DEN) for 16 weeks. After HQHF intervention, liver function, lipid metabolism, inflammation, and tumor markers were measured. Western blotting, RT-qPCR, H&E staining, Oil Red O staining, and ELISA were used to analyze the regulatory effect of HQHF on the NETs/CD4 + T/Tregs pathway. Results Model rats showed obvious liver damage, steatosis, atypical hyperplasia, and tumor nodules, accompanied by disordered lipid metabolism, elevated inflammatory factors and tumor markers, and upregulated expressions of NETs, Tregs, and mitochondrial oxidative phosphorylation–related markers. HQHF treatment alleviated liver injury, reduced tumor nodules, corrected lipid metabolism disorders, and downregulated the expressions of Cit-H3, FoxP3, and NDUFB8 in liver tissue. Conclusion HQHF is positively correlated with the improvement of hepatic steatosis, inflammation, and fibrosis in MASH-HCC rats. HQHF may serve as a valuable intervention candidate for ameliorating inflammation-cancer transformation in MASH-HCC. Our study in MASH-HCC rat models indicates a potential association between HQHF and the NETs/CD4 + T/Tregs axis. Cellular-level studies are required to establish direct causality, offering preliminary evidence for MASH-HCC therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: